IVIG: Clinical Trials

26 trials of IVIG, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

12 completed, 3 recruiting, 3 unknown, 2 active not recruiting. 26 Phase 3, 8 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 326Completed 12, Recruiting 3, Unknown 3, Active not recruiting 2, Not yet recruiting 2, Terminated 2, Withdrawn 2
Phase 28Completed 3, Active not recruiting 1, Not yet recruiting 1, Recruiting 1, Terminated 1, Withdrawn 1

Follow IVIG: new trials by email Literature Review of IVIG trials Research Report on IVIG

Trials (filtered) newest first · largest first

All 26 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Efficacy and Safety of Immunoglobulin Plus Firsekibart in Patients With Kawasaki Disease
IVIG, Aspirin, Firsekibart - Kawasaki Disease
Phase 2 / Phase 3Not yet recruitingChildren's Hospital of Fudan University902026-11-012026-10-22
IVIG Boya: Safety, Efficacy, and Pharmacokinetics
Boya IVIG - Primary Immunodeficiency Disease
Phase 3Not yet recruitingAzidus Brasil502026-09-012026-06-03
A Study to Assess Efficacy and Safety of Empasiprubart Versus IVIg in Adults With CIDP
empasiprubart, IVIg, empasiprubart-placebo - Chronic Inflammatory Demyelinating Polyneuropathy, CIDP
Phase 3Recruitingargenx2182025-08-222026-11-16
Role of Antibiotic Therapy or Immunoglobulin On iNfections in hAematoLogy Dosing Immunoglobulin (Dose Ig)
Immune Globulin Intravenous - Myeloma, Non Hodgkin's Lymphoma
Phase 2 / Phase 3RecruitingMonash University9002025-04-282025-10-07
A Study to Test the Efficacy and Safety of Riliprubart Against the Usual Treatment of Intravenous Immunoglobulin (IVIg) in People With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
riliprubart, Placebo, IVIg - Chronic Inflammatory Demyelinating Polyneuropathy
Phase 3RecruitingSanofi1602024-08-212026-10-19
Efficacy, Safety, and Pharmacokinetics of Shu Yang IVIG
IVIG - Primary Immunodeficiency Disease
Phase 3UnknownAzidus Brasil502024-04-012024-03-12
The Effects Of Therapeutic Plasma Exchange (TPE) On Age Related Biomarkers And Epigenetics
Sham, Therapeutic Plasma Exchange, IVIG - Aging
Phase 3UnknownDobri Kiprov402022-09-122024-08-02
Renal Function in Highly Sensitized Patients 1 Year After Desensitization With Imlifidase Prior to DD Kidney Tx
Imlifidase, PLEX, IVIg - Kidney Transplantation in Highly Sensitized Patients
Phase 3CompletedHansa Biopharma AB642021-10-142026-04-30
IVIG Versus Plasmapheresis in the Treatment of Guillian Barrie Syndrome Patients
plasmapheresis device, Intravenous immunoglobulin - Guillain-Barre Syndrome
Phase 2 / Phase 3CompletedAssiut University812021-09-012023-04-06
Efficacy of Immunoglobulin Plus Infliximab for the Early Regression of Coronary Artery Lesion in Kawasaki Disease
IVIG, Aspirin, Infliximab - Kawasaki Disease
Phase 3WithdrawnChildren's Hospital of Fudan University2020-10-012021-03-12
Surveillance and Treatment to Prevent Fetal Atrioventricular Block Likely to Occur Quickly (STOP BLOQ)
Dexamethasone, IVIG - AVB - Atrioventricular Block, Fetal AVB
Phase 3Active not recruitingNYU Langone Health13002020-08-012026-08-25
rATG Versus rATG Combined With Intravenous Immunoglobulin (IVIG) Induction Immunosuppression in HLA Incompatible Transplantation (INHIBIT)
Privigen, Thymoglobulin, Plasma Exchange - Kidney Transplantation
Phase 3CompletedInstitute for Clinical and Experimental Medicine172020-07-272024-08-15
Intravenous Immunoglobulin (IVIG, Bioven) Efficacy Assess for COVID-19 / SARS-CoV-2 Severe Pneumonia Complex Treatment
IVIG - Covid19, Pneumonia
Phase 3CompletedBiopharma Plasma LLC762020-05-072020-10-14
Efficacy of Immunoglobulin Plus Prednisolone in Reducing Coronary Artery Lesion in Patients With Kawasaki Disease
IVIG, Aspirin, Prednisolone - Kawasaki Disease
Phase 3CompletedChildren's Hospital of Fudan University32082020-01-152026-04-16
Autologous Transplant To End NMO Spectrum Disorder
Rituximab, Cyclophosphamide, Mesna - Neuromyelitis Optica, Devic's Disease
Phase 2 / Phase 3WithdrawnNorthwestern University2019-11-012019-11-20
Eltrombopag vs Standard Front Line Management for Newly Diagnosed Immune Thrombocytopenia (ITP) in Children
Eltrombopag, Steroids, IVIG - Immune Thrombocytopenia
Phase 3CompletedBaylor College of Medicine1222019-05-022025-07-29
Etoposide in the First-line Treatment of Adult EBV-HLH
Etoposide, Dexamethasone, IVIG - Hemophagocytic Lymphohistiocytosis
Phase 3UnknownBeijing Friendship Hospital902018-12-012018-11-15
Cardiac Safe Transplants for Systemic Sclerosis
Rituximab, Fludarabine, Cyclophosphamide - Systemic Sclerosis, Scleroderma
Phase 2 / Phase 3TerminatedNorthwestern University92018-05-172020-08-12
Maximizing Outcome of Multiple Sclerosis Transplantation
Cyclophosphamide, Mesna, rATG - Multiple Sclerosis, Relapsing-Remitting
Phase 3TerminatedNorthwestern University662017-11-082021-01-11
KIDCARE (Kawasaki Disease Comparative Effectiveness Trial)
IVIG, Infliximab - Mucocutaneous Lymph Node Syndrome
Phase 3CompletedUniversity of California, San Diego1052017-02-172021-12-03

Showing 20 of 26. Sign in to see all of them.

Conditions studied

Mucocutaneous Lymph Node Syndrome (5)  ·  Polyradiculoneuropathy, Chronic Inflammatory Demyelinating (3)  ·  Primary Immunodeficiency Diseases (2)  ·  Atrioventricular Block (1)  ·  Bruton type agammaglobulinemia (1)  ·  COVID-19 (1)  ·  Common Variable Immunodeficiency (1)  ·  Coronavirus Infections (1)  ·  Guillain-Barre Syndrome (1)  ·  Histiocytosis, Langerhans-Cell (1)  ·  Infections (1)  ·  Leukemia (1)  ·  Lymphohistiocytosis, Hemophagocytic (1)  ·  Lymphoma (1)  ·  Meningitis (1)

Sponsors

Children's Hospital of Fudan University (3)  ·  Northwestern University (3)  ·  Azidus Brasil (2)  ·  Assiut University (1)  ·  Baylor College of Medicine (1)  ·  Beijing Friendship Hospital (1)  ·  Biopharma Plasma LLC (1)  ·  Dobri Kiprov (1)  ·  Fudan University (1)  ·  Grifols Therapeutics LLC (1)  ·  Hansa Biopharma AB (1)  ·  Haukeland University Hospital (1)  ·  Hormozgan University of Medical Sciences (1)  ·  Institute for Clinical and Experimental Medicine (1)  ·  Monash University (1)

Countries

United States (13)  ·  China (6)  ·  Canada (4)  ·  Czechia (4)  ·  Argentina (3)  ·  Germany (3)  ·  Israel (3)  ·  Italy (3)  ·  Australia (2)  ·  Brazil (2)  ·  France (2)  ·  Greece (2)  ·  Hungary (2)  ·  Japan (2)  ·  Mexico (2)

Top investigators

Richard Burt, MD (3)  ·  Luciana Ferrara (2)  ·  Amanda Grimes, MD (1)  ·  Avroy A. Fanaroff, MD (1)  ·  Bettina Cuneo, MD (1)  ·  Carlos Rodriguez-Galindo, MD (1)  ·  Charles R. Bauer, MD (1)  ·  Dobri Kiprov, MD (1)  ·  Elisabeth Farbu, MD, PhD (1)  ·  Elizabeth C. Wright, PhD (1)  ·  Fang Liu, MD (1)  ·  Fang Liu, MD. (1)  ·  Guoying Huang, MD. (1)  ·  Jane C Burns, MD (1)

Results publications

PMID 18178525, PMID 19260050, PMID 19365055, PMID 19496683, PMID 20457948, PMID 20647554, PMID 20837852, PMID 32612255, PMID 34452956, PMID 34715057, PMID 34895290, PMID 37947364, PMID 40424097, PMID 40458542, PMID 41123939, PMID 41985133, PMID 8133853, PMID 9686724

NIH funding

2023 (1), U01HD019897 (1), U10HD021364 (1), U10HD021373 (1), U10HD021385 (1), U10HD021397 (1), U10HD021415 (1)